|
USP14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.915440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.502100E-02 |
| Normal-vs-Stage2 |
9.043200E-01 |
| Normal-vs-Stage3 |
7.403800E-01 |
| Normal-vs-Stage4 |
5.525600E-01 |
| Stage1-vs-Stage2 |
4.138800E-01 |
| Stage1-vs-Stage3 |
4.820000E-01 |
| Stage1-vs-Stage4 |
9.674400E-01 |
| Stage2-vs-Stage3 |
8.690400E-01 |
| Stage2-vs-Stage4 |
5.972600E-01 |
| Stage3-vs-Stage4 |
7.155000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.408820E-01 |
| Normal-vs-AfricanAmerican |
2.784400E-01 |
| Normal-vs-Asian |
6.428000E-01 |
| Caucasian-vs-AfricanAmerican |
9.796200E-01 |
| Caucasian-vs-Asian |
9.007200E-01 |
| AfricanAmerican-vs-Asian |
9.032800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.698020E-02 |
| Normal-vs-Female |
1.675980E-01 |
| Male-vs-Female |
1.342180E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.192200E-01 |
| Normal-vs-Extreme_Weight |
2.916700E-03 |
| Normal-vs-Obese |
5.309400E-01 |
| Normal-vs-Extreme_Obese |
6.060600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.569750E-01 |
| Normal_Weight-vs-Obese |
9.176400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.757800E-01 |
| Extreme_Weight-vs-Obese |
8.620100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.074600E-01 |
| Obese-vs-Extreme_Obese |
8.184800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.879800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.616800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.095600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.610450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.854000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.644000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.419600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.707900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.618800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.111400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.994450E-02 |
| Normal-VS-Type2 PRCC |
7.037000E-01 |
| Normal-VS-KIRP CIMP |
3.348200E-01 |
| Normal-VS-Unclassified PRCC |
7.224200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.619000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.025700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.411800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.750200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.847400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.739600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.981900E-02 |
| Normal-vs-N1 |
7.101400E-01 |
| Normal-vs-N2 |
8.244200E-01 |
| N0-vs-N1 |
7.819500E-02 |
| N0-vs-N2 |
7.501600E-01 |
| N1-vs-N2 |
6.434000E-01 |
|
|
